• HTLV-1
    0
    AVAILABLE TECHNOLOGY | Rare disease – Adult T-cell Leukemia (ATL) – HTLV-1
  • TESOVIR
    0
    AVAILABLE TECHNOLOGY | HIV Reservoir – Biomarkers – mAb
  • LRAs
    0
    AVAILABLE TECHNOLOGY | HIV – Shock & Kill Strategy – LRAs
  • TARMAK
    0
    AVAILABLE TECHNOLOGY | Therapeutic combination – Synergy effect in pharmacology – Prostate cancer
  • INNOVAC PPR
    0
    AVAILABLE TECHNOLOGY | “Peste des Petits Ruminants” (PPR, sheep and goat plague) – Innovative vaccines – DIVA (“Differentiating Infected from Vaccinated Animals”)
  • MSC 2.0
    1
    AVAILABLE TECHNOLOGY | Myocardial infarction – Human mesenchymal stem cells – Innovative cell therapy
  • 3D-CELLS
    0
    AVAILABLE TECHNOLOGY | Sub-micron fiber matrix – Electrospinning – 3D cell culture
  • PERSPECTYV
    0
    AVAILABLE TECHNOLOGY | Facioscapulohumeral dystrophy – Personalized treatment –
  • RESIST-430
    0
    AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Gamma-peptides
123